Search Results for
“Telegram 订阅👉【SMMFS.COM】引流强拉 引流,18n”
March 16, 2022
Available Volunteer Opportunities Bone Health Education Presenter – Virtual Bone Health Education Volunteers work together with the Community Engagement Coordinators and are an integral part in the planning and facilitating […]
May 25, 2020
Members of Osteoporosis Canada’s Scientific Advisory Council would like announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. Osteoporosis Canada established this award in 1993 […]
![](/wp-content/themes/yootheme/cache/cc/1-3-PROTEIN-ccbf8a24.jpeg)
November 21, 2018
Today, most people consume too much protein at dinner and not enough at breakfast. In recent years, scientific studies have shown that a balanced consumption of protein throughout the day […]
April 8, 2019
Facts & Stats Learn more about osteoporosis and related fractures Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue which can lead to increased risk […]
![](/wp-content/themes/yootheme/cache/7c/CHRISTINE-THOMAS-600-375-7c7ecdc7.jpeg)
May 18, 2020
Christine Thomas was only 42 when, bending to lift her newborn daughter, she fractured her spine. Diagnosed with five vertebral fractures as a result of unsuspected osteoporosis, she had no idea of the painful and transformative road she would have to travel to build stronger bones and reclaim her life.
November 11, 2010
We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]
April 11, 2012
A recently released Canadian research study confirms what has been shown in past preliminary studies; – inflammation of the eye as a possible side effect of bisphosphonate therapy is very […]
October 23, 2018
Denosumab (Prolia) has been shown to reduce the risk of fracture in postmenopausal women and men ≥50 years old with osteoporosis. It has also been approved for steroid induced bone […]
November 27, 2008
We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]